Sequencing Pancreatic Juice: Squeezing the Most Out of Surveillance.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29500277.
- Also identified by DOI 10.1158/1078-0432.CCR-18-0215 and PMC identifier 6295911.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Next-generation sequencing of pancreatic juice can detect and quantify tumor-promoting mutations, supporting imaging and cytology findings to predict the degree of dysplasia in patients at high risk for pancreatic cancer. Future studies are needed to optimize this approach and determine how it best fits into clinical practice. <i>Clin Cancer Res; 24(12); 2713-5. ©2018 AACR</i><i>See related article by Suenaga et al., p. 2963</i>.
Medical subject headings
- Pancreatic Juice
- Pancreatic Neoplasms